BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 11820371)

  • 1. Elongated growth of octacalcium phosphate crystals in recombinant amelogenin gels under controlled ionic flow.
    Iijima M; Moriwaki Y; Wen HB; Fincham AG; Moradian-Oldak J
    J Dent Res; 2002 Jan; 81(1):69-73. PubMed ID: 11820371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions of amelogenins with octacalcium phosphate crystal faces are dose dependent.
    Iijima M; Moradian-Oldak J
    Calcif Tissue Int; 2004 Jun; 74(6):522-31. PubMed ID: 15354860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assembly of amelogenin proteolytic products and control of octacalcium phosphate crystal morphology.
    Moradian-Oldak J; Iijima M; Bouropoulos N; Wen HB
    Connect Tissue Res; 2003; 44 Suppl 1():58-64. PubMed ID: 12952175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modification of calcium-phosphate coatings on titanium by recombinant amelogenin.
    Wen HB; Moradian-Oldak J
    J Biomed Mater Res A; 2003 Mar; 64(3):483-90. PubMed ID: 12579562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose-dependent modulation of octacalcium phosphate crystal habit by amelogenins.
    Wen HB; Moradian-Oldak J; Fincham AG
    J Dent Res; 2000 Nov; 79(11):1902-6. PubMed ID: 11145363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Control of apatite crystal growth by the co-operative effect of a recombinant porcine amelogenin and fluoride.
    Iijima M; Du C; Abbott C; Doi Y; Moradian-Oldak J
    Eur J Oral Sci; 2006 May; 114 Suppl 1():304-7; discussion 327-9, 382. PubMed ID: 16674703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of apatite crystal growth on Bioglass by recombinant amelogenin.
    Wen HB; Moradian-Oldak J; Fincham AG
    Biomaterials; 1999 Sep; 20(18):1717-25. PubMed ID: 10503973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of amelogenin with hydroxyapatite crystals: an adherence effect through amelogenin molecular self-association.
    Moradian-Oldak J; Tan J; Fincham AG
    Biopolymers; 1998 Oct; 46(4):225-38. PubMed ID: 9715666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of recombinant mouse amelogenins on the formation and organization of hydroxyapatite crystals in vitro.
    Beniash E; Simmer JP; Margolis HC
    J Struct Biol; 2005 Feb; 149(2):182-90. PubMed ID: 15681234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Control of apatite crystal growth in a fluoride containing amelogenin-rich matrix.
    Iijima M; Moradian-Oldak J
    Biomaterials; 2005 May; 26(13):1595-603. PubMed ID: 15522761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of self-assembly and apatite binding properties of amelogenin proteins lacking the hydrophilic C-terminal.
    Moradian-Oldak J; Bouropoulos N; Wang L; Gharakhanian N
    Matrix Biol; 2002 Mar; 21(2):197-205. PubMed ID: 11852235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amelogenin control over apatite crystal growth is affected by the pH and degree of ionic saturation.
    Habelitz S; Denbesten PK; Marshall SJ; Marshall GW; Li W
    Orthod Craniofac Res; 2005 Nov; 8(4):232-8. PubMed ID: 16238603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progressive accretion of amelogenin molecules during nanospheres assembly revealed by atomic force microscopy.
    Wen HB; Fincham AG; Moradian-Oldak J
    Matrix Biol; 2001 Sep; 20(5-6):387-95. PubMed ID: 11566273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Supramolecular assembly of amelogenin nanospheres into birefringent microribbons.
    Du C; Falini G; Fermani S; Abbott C; Moradian-Oldak J
    Science; 2005 Mar; 307(5714):1450-4. PubMed ID: 15746422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The onset of amelogenin nanosphere aggregation studied by small-angle X-ray scattering and dynamic light scattering.
    Aichmayer B; Margolis HC; Sigel R; Yamakoshi Y; Simmer JP; Fratzl P
    J Struct Biol; 2005 Sep; 151(3):239-49. PubMed ID: 16125972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative analysis of amelogenin solubility.
    Tan J; Leung W; Moradian-Oldak J; Zeichner-David M; Fincham AG
    J Dent Res; 1998 Jun; 77(6):1388-96. PubMed ID: 9649167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Self-assembly and effect on crystal growth of the leucine-rich amelogenin peptide.
    Habelitz S; DenBesten PK; Marshall SJ; Marshall GW; Li W
    Eur J Oral Sci; 2006 May; 114 Suppl 1():315-9; discussion 327-9, 382. PubMed ID: 16674705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of hydroxyapatite surface coverage by amelogenin nanospheres following the Langmuir model for protein adsorption.
    Bouropoulos N; Moradian-Oldak J
    Calcif Tissue Int; 2003 May; 72(5):599-603. PubMed ID: 12704567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amelogenin supra-molecular assembly in vitro compared with the architecture of the forming enamel matrix.
    Moradian-Oldak J; Goldberg M
    Cells Tissues Organs; 2005; 181(3-4):202-18. PubMed ID: 16612086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Self-assembly properties of recombinant engineered amelogenin proteins analyzed by dynamic light scattering and atomic force microscopy.
    Moradian-Oldak J; Paine ML; Lei YP; Fincham AG; Snead ML
    J Struct Biol; 2000 Jul; 131(1):27-37. PubMed ID: 10945967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.